VELOCI-BI
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 02 Mar 2026)
What this means for you
Registered since 17 Dec 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88212568
- Registration number
- 5939741
- Mark type
- Stylized text
- Filed
- 30 Nov 2018
- Published for opposition
- 19 Feb 2019
- Registered
- 17 Dec 2019
- Attorney of record
- Terrence J. McAllister
Goods and services
- Class 042 — Scientific and technological services: Genetic engineering services, namely, the production of genetically-engineered antibodies for others
Owner
- Regeneron Pharmaceuticals, Inc., Tarrytown, NY, US
- Regeneron Pharmaceuticals, Inc., Tarrytown, NY, US
- Regeneron Pharmaceuticals, Inc., Tarrytown, NY, US
Prosecution history
- 02 Mar 2026 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 02 Mar 2026 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 02 Mar 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 24 Nov 2025 — TEAS SECTION 8 & 15 RECEIVED
- 30 Jun 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 30 Jun 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 30 Jun 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 30 Jun 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 30 Jun 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 17 Dec 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 14 Jul 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 14 Jul 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 14 Jul 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 17 Dec 2019 — REGISTERED-PRINCIPAL REGISTER
- 13 Nov 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED